Compulsory licensing of pharmaceuticals : a review of Section 41 of the Patent Act.: RG15-2/1983E-PDF ; RG15-2/1983-PDF

"This paper reviews the effect of the 1969 Patent Act revisions on the drug industry in Canada. It analyzes how these changes have affected the activities of the pharmaceutical industry, the prices of prescription drugs and the current investment climate in Canada. It also considers, in line with government policy to stimulate high technology industry, a number of possible changes to the Patent Act that may improve the investment climate for major pharmaceutical firms while assuring a continued supply of reasonably priced drugs for Canadians"--Introduction, page 1.

Permanent link to this Catalogue record:

Publication information
Department/Agency Canada. Consumer and Corporate Affairs Canada, issuing body.
Title Compulsory licensing of pharmaceuticals : a review of Section 41 of the Patent Act.
Publication type Monograph
Language [English]
Other language editions [French]
Format Electronic
Electronic document
Note(s) Issued also in French under title: Octroi obligatoire de licences dans le domaine des produits pharmaceutiques : révision de l'article 41 de la Loi sur les brevets.
"June 1983."
Digitized edition from print [produced by Innovation, Science and Economic Development Canada].
Includes bibliographical references.
Publishing information [Ottawa] : Consumer and Corporate Affairs Canada = Consommation et corporations Canada, 1983.
Description 1 online resource (ix, 64 pages) : illustrations
ISBN 0662525329
Catalogue number
  • RG15-2/1983E-PDF
  • RG15-2/1983-PDF
Subject terms Canada. Patent Act.
Pharmaceutical industry -- Canada.
Drugs -- Prices -- Canada.
Compulsory licensing of patents -- Canada.
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.
Date modified: